APA (7th ed.) Citation

Sabio, E., & Chan, T. A. (2019). The good, the bad, and the ugly: Hyperprogression in cancer patients following immune checkpoint therapy. Genome medicine, 11(1), 43-3. https://doi.org/10.1186/s13073-019-0661-7

Chicago Style (17th ed.) Citation

Sabio, Erich, and Timothy A. Chan. "The Good, the Bad, and the Ugly: Hyperprogression in Cancer Patients Following Immune Checkpoint Therapy." Genome Medicine 11, no. 1 (2019): 43-3. https://doi.org/10.1186/s13073-019-0661-7.

MLA (9th ed.) Citation

Sabio, Erich, and Timothy A. Chan. "The Good, the Bad, and the Ugly: Hyperprogression in Cancer Patients Following Immune Checkpoint Therapy." Genome Medicine, vol. 11, no. 1, 2019, pp. 43-3, https://doi.org/10.1186/s13073-019-0661-7.